Metal Nanoparticle Agglomerates for Low-Toxicity Antiseptic Substrates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing infection control methods, including first aid kits and common disinfectants, are inadequate against antibiotic-resistant bacteria and viruses, particularly in remote or unsterile environments, and fail to effectively prevent or treat topical infections.
Innovation Solution
Metal nanoparticle agglomerates, adhered to a base substrate or dispersed in a fluid medium, provide rapid and sustained disinfection by inactivating infective agents through multiple biocidal pathways, promoting wound healing, and are incorporated into various products for skin and oral disinfection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional disinfectants and first aid agents are used, then basic infection control is provided, but they are ineffective against antibiotic-resistant bacteria and viruses
Solution Approach 1:
The patent changes the chemical parameters of disinfection agents by using metal nanoparticle agglomerates (silver, copper, zinc, aluminum, or their alloys) instead of conventional chemical disinfectants. These nanoparticles exhibit enhanced biocidal activity against antibiotic-resistant bacteria and viruses through mechanisms including membrane disruption, oxidative stress induction, and interference with microbial metabolism, providing reliable infection control where conventional agents fail.
Solution Approach 2:
The patent employs composite material structures by combining metal nanoparticles with agglomerating agents and stabilizers to create multifunctional disinfection formulations. The composite nature of these agglomerates provides both the biocidal activity of metal nanoparticles and the stabilizing effects of organic compounds, enabling effective and sustained action against a broad spectrum of infective agents including resistant strains.
2Reliability
If aggressive treatment is applied to prevent infection, then infection control is improved, but toxicity increases
Solution Approach 1:
The patent applies local quality control by designing metal nanoparticle agglomerates that concentrate biocidal activity specifically at the site of infection or potential infection (wound site, skin surface, oral cavity). The nanoparticles are formulated to interact preferentially with microbial cells rather than host tissue, providing localized antimicrobial action while minimizing systemic toxicity and collateral damage to healthy cells.
Solution Approach 2:
The patent incorporates dynamic release mechanisms where metal nanoparticles are gradually released from the agglomerate structure over time. This dynamic release profile maintains effective biocidal concentrations at the treatment site while avoiding excessive local concentrations that could cause toxicity. The agglomerate structure acts as a reservoir, providing sustained action with reduced peak exposure to both pathogens and host tissue.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Metal nanoparticle agglomerates effectively inactivate a range of microorganisms, including antibiotic-resistant bacteria and viruses, while minimizing toxicity and maintaining biocidal activity for extended periods, suitable for use in first aid kits and medical settings.
Implementation Method 1
metal nanoparticle agglomerates... inactivating infective agents through multiple biocidal pathways
Data Source
AI summary
Metal nanoparticle agglomerates in various forms may be utilized to promote infection control. Antiseptic substrates may comprise a base substrate and metal nanoparticle agglomerates adhered thereto. Metal nanoparticle agglomerates upon the antiseptic substrates may be contacted with a skin penetration, a skin injury, a burn, a site to be subjected to a skin penetration, or an active skin infection to provide infection control against at least one infective agent. The antiseptic substrates may also facilitate water purification in some cases. Antiseptic fluid formulations comprising a fluid medium having metal nanoparticle agglomerates dispersed therein may be configured for topical or oral use and may similarly afford infection control. Creams, ointments, balms, salves, gels, and liquids or liquid suspensions containing metal nanoparticle agglomerates may be effective for promoting infection control and/or for treating an active infection.